Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes.

Llovet JM, Rodríguez-Iglesias P, Moitinho E, Planas R, Bataller R, Navasa M, Menacho M, Pardo A, Castells A, Cabré E, Arroyo V, Gassull MA, Rodés J.

J Hepatol. 1997 Jan;26(1):88-95.

PMID:
9148028
2.

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

Novella M, Solà R, Soriano G, Andreu M, Gana J, Ortiz J, Coll S, Sàbat M, Vila MC, Guarner C, Vilardell F.

Hepatology. 1997 Mar;25(3):532-6.

PMID:
9049193
3.

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Fernández J, Navasa M, Gómez J, Colmenero J, Vila J, Arroyo V, Rodés J.

Hepatology. 2002 Jan;35(1):140-8.

PMID:
11786970
4.

[Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].

Aparicio JR, Such J, Gutiérrez A, Pérez-Mateo M, Plaza J, Arroyo A.

Med Clin (Barc). 1999 Sep 11;113(7):241-5. Spanish.

PMID:
10544377
5.

Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.

Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK.

J Gastroenterol Hepatol. 2005 Apr;20(4):599-605.

PMID:
15836710
6.

[Spontaneous infection of ascitic fluid due to Salmonella typhimurium in a cirrhotic patient undergoing selective intestinal decontamination with norfloxacin].

Lecleire S, Di Fiore F, Hervé S, Goria O, Savoye G, Colin R, Lerebours E.

Presse Med. 2003 Mar 29;32(12):550-2. French.

PMID:
12714922
7.

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial.

Ginés P, Rimola A, Planas R, Vargas V, Marco F, Almela M, Forné M, Miranda ML, Llach J, Salmerón JM, et al.

Hepatology. 1990 Oct;12(4 Pt 1):716-24.

PMID:
2210673
8.

Selective intestinal decontamination prevents spontaneous bacterial peritonitis.

Soriano G, Guarner C, Teixidó M, Such J, Barrios J, Enríquez J, Vilardell F.

Gastroenterology. 1991 Feb;100(2):477-81.

PMID:
1985045
9.

Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.

Ortiz J, Vila MC, Soriano G, Miñana J, Gana J, Mirelis B, Novella MT, Coll S, Sábat M, Andreu M, Prats G, Solá R, Guarner C.

Hepatology. 1999 Apr;29(4):1064-9.

PMID:
10094947
10.
11.

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.

Grangé JD, Roulot D, Pelletier G, Pariente EA, Denis J, Ink O, Blanc P, Richardet JP, Vinel JP, Delisle F, Fischer D, Flahault A, Amiot X.

J Hepatol. 1998 Sep;29(3):430-6.

PMID:
9764990
13.

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.

Fernández J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, Vila C, Pardo A, Quintero E, Vargas V, Such J, Ginès P, Arroyo V.

Gastroenterology. 2007 Sep;133(3):818-24. Epub 2007 Jul 3.

PMID:
17854593
14.

Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.

Alvarez RF, Mattos AA, Corrêa EB, Cotrim HP, Nascimento TV.

Arq Gastroenterol. 2005 Oct-Dec;42(4):256-62. Epub 2006 Jan 19.

15.

Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin.

Campillo B, Dupeyron C, Richardet JP, Mangeney N, Leluan G.

Clin Infect Dis. 1998 May;26(5):1066-70.

PMID:
9597225
16.

Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.

Elfert A, Abo Ali L, Soliman S, Ibrahim S, Abd-Elsalam S.

Eur J Gastroenterol Hepatol. 2016 Dec;28(12):1450-1454.

PMID:
27512927
17.

Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.

Corradi F, Brusasco C, Fernández J, Vila J, Ramirez MJ, Seva-Pereira T, Fernández-Varo G, Mosbah IB, Acevedo J, Silva A, Rocco PR, Pelosi P, Gines P, Navasa M.

Dig Liver Dis. 2012 Mar;44(3):239-44. doi: 10.1016/j.dld.2011.10.014. Epub 2011 Nov 25.

PMID:
22119621
18.

Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.

Fernández J, Ruiz del Arbol L, Gómez C, Durandez R, Serradilla R, Guarner C, Planas R, Arroyo V, Navasa M.

Gastroenterology. 2006 Oct;131(4):1049-56; quiz 1285.

PMID:
17030175
19.

Role of immunosuppression in the development of quinolone-resistant Escherichia coli spontaneous bacterial peritonitis and in the mortality of E. coli spontaneous bacterial peritonitis.

Cereto F, Molina I, González A, Del Valle O, Esteban R, Guardia J, Genescà J.

Aliment Pharmacol Ther. 2003 Mar 1;17(5):695-701.

20.

Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis.

Arroyo V, Navasa M, Rimola A.

Infection. 1994;22 Suppl 3:S167-75. Review.

PMID:
7843826

Supplemental Content

Support Center